Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,305 | 682 | 54.6% |
| Consulting Fee | $7,155 | 2 | 31.7% |
| Travel and Lodging | $2,991 | 9 | 13.3% |
| Education | $89.24 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $9,667 | 158 | $0 (2024) |
| Medtronic, Inc. | $1,598 | 17 | $0 (2024) |
| Medtronic MiniMed, Inc. | $1,191 | 7 | $0 (2020) |
| Dexcom, Inc. | $1,182 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,075 | 65 | $0 (2023) |
| Lilly USA, LLC | $1,047 | 58 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $922.36 | 55 | $0 (2023) |
| Amgen Inc. | $907.24 | 40 | $0 (2024) |
| Abbott Laboratories | $793.03 | 41 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $788.81 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,631 | 69 | Medtronic, Inc. ($1,498) |
| 2023 | $1,261 | 76 | Novo Nordisk Inc ($293.41) |
| 2022 | $2,840 | 161 | Novo Nordisk Inc ($700.01) |
| 2021 | $2,986 | 170 | Novo Nordisk Inc ($464.31) |
| 2020 | $1,787 | 107 | Novo Nordisk Inc ($282.04) |
| 2019 | $9,752 | 104 | Novo Nordisk Inc ($7,691) |
| 2018 | $1,218 | 8 | Medtronic MiniMed, Inc. ($1,094) |
| 2017 | $64.92 | 1 | Medtronic MiniMed, Inc. ($64.92) |
All Payment Transactions
696 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $6.42 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $95.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Durable Pump | ||||||
| 12/09/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $20.74 | General |
| Category: Insulin Pump | ||||||
| 11/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $43.56 | General |
| Category: Endocrinology | ||||||
| 10/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Endocrinology | ||||||
| 10/01/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $16.67 | General |
| Category: Insulin Pump | ||||||
| 09/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Diabetes Care | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Endocrinology | ||||||
| 09/03/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Durable Pump | ||||||
| 08/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Diabetes Care | ||||||
| 08/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: DIABETES | ||||||
| 08/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Biological | ||||||
| 08/13/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| Category: Insulin Pump | ||||||
| 08/05/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.88 | General |
| Category: Insulin Pump | ||||||
| 07/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 232 | 289 | $52,860 | $15,654 |
| 2022 | 15 | 808 | 1,963 | $258,747 | $81,378 |
| 2021 | 14 | 946 | 2,122 | $288,402 | $93,418 |
| 2020 | 8 | 740 | 1,003 | $170,319 | $55,054 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 163 | $43,792 | $13,448 | 30.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 24 | 33 | $3,300 | $862.72 | 26.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 16 | $2,560 | $619.92 | 24.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 49 | 61 | $2,440 | $580.72 | 23.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 16 | $768.00 | $142.37 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 269 | 405 | $108,780 | $32,785 | 30.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 11 | 780 | $36,660 | $13,330 | 36.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 83 | 97 | $36,181 | $12,003 | 33.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 62 | 96 | $18,044 | $5,643 | 31.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $13,104 | $4,319 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $7,068 | $2,365 | 33.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 41 | $6,765 | $2,272 | 33.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 44 | 94 | $9,400 | $2,260 | 24.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $4,650 | $1,581 | 34.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 104 | 161 | $6,440 | $1,503 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 17 | $3,220 | $1,110 | 34.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 31 | $2,759 | $922.71 | 33.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 12 | 16 | $1,812 | $477.12 | 26.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 43 | $2,064 | $452.55 | 21.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 98 | 120 | $1,800 | $353.03 | 19.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 328 | 550 | $145,867 | $46,699 | 32.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 130 | 225 | $39,894 | $14,355 | 36.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 11 | 660 | $31,020 | $11,157 | 36.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 45 | 49 | $17,854 | $6,104 | 34.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $13,392 | $4,065 | 30.4% |
About Dr. John Epling, M.D
Dr. John Epling, M.D is a Gastroenterology healthcare provider based in Bridgeport, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2013. The National Provider Identifier (NPI) number assigned to this provider is 1811332166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Epling, M.D has received a total of $22,540 in payments from pharmaceutical and medical device companies, with $2,631 received in 2024. These payments were reported across 696 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($12,305).
As a Medicare-enrolled provider, Epling has provided services to 2,726 Medicare beneficiaries, totaling 5,377 services with total Medicare billing of $245,504. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Diabetes & Metabolism
- Location Bridgeport, WV
- Active Since 04/30/2013
- Last Updated 04/06/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1811332166
Products in Payments
- Victoza (Drug) $7,372
- MINIMED 780G (Device) $1,579
- Ozempic (Drug) $1,158
- Minimed 670G System (Device) $1,094
- FARXIGA (Drug) $1,091
- t-slim insulin pump (Device) $735.78
- Dexcom G6 Transmitter (Medical Supply) $626.49
- SOLIQUA 100/33 (Biological) $609.33
- Rybelsus (Drug) $573.63
- EVENITY (Biological) $558.35
- FreeStyle Libre (Device) $478.67
- TRADJENTA (Drug) $466.33
- DEXCOM G6 TRANSMITTER (Device) $408.74
- Omnipod (Device) $400.34
- JARDIANCE (Drug) $293.93
- TRULICITY (Drug) $292.16
- MOUNJARO (Drug) $283.52
- Repatha (Biological) $253.13
- VOQUEZNA (Drug) $230.25
- BAQSIMI (Drug) $225.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Bridgeport
Dr. David Ciarolla, Md, MD
Gastroenterology — Payments: $9,620
Mrs. Kimberly Fairley, Do, DO
Gastroenterology — Payments: $1,491
Dr. Siva Prasad Maruboyina, M.d, M.D
Gastroenterology — Payments: $805.63
Dr. Caroline Loeser, Md, MD
Gastroenterology — Payments: $592.30
Ms. Gracia Viana Rodriguez, M.d, M.D
Gastroenterology — Payments: $318.91
David Grayer, M.d, M.D
Gastroenterology — Payments: $34.43